Year |
Citation |
Score |
2022 |
Woods-Burnham L, Stiel L, Martinez SR, Sanchez-Hernandez ES, Ruckle HC, Almaguel FG, Stern MC, Roberts LR, Williams DR, Montgomery S, Casiano CA. Psychosocial Stress, Glucocorticoid Signaling, and Prostate Cancer Health Disparities in African American Men. Cancer Health Disparities. 4. PMID 35252767 |
0.781 |
|
2021 |
Johnson JR, Woods-Burnham L, Hooker SE, Batai K, Kittles RA. Genetic Contributions to Prostate Cancer Disparities in Men of West African Descent. Frontiers in Oncology. 11: 770500. PMID 34820334 DOI: 10.3389/fonc.2021.770500 |
0.392 |
|
2020 |
Bathina M, Woods-Burnham L, Walker MS, Kimbro KS, Kittles RA. Abstract D114: VIitamin D signaling of immune-related genes in diverse prostate cancer cancer cell lines Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp19-D114 |
0.504 |
|
2018 |
Woods-Burnham L, Cajigas-Du Ross CK, Love A, Basu A, Sanchez-Hernandez ES, Martinez SR, Ortiz-Hernández GL, Stiel L, Durán AM, Wilson C, Montgomery S, Roy S, Casiano CA. Glucocorticoids Induce Stress Oncoproteins Associated with Therapy-Resistance in African American and European American Prostate Cancer Cells. Scientific Reports. 8: 15063. PMID 30305646 DOI: 10.1038/S41598-018-33150-2 |
0.703 |
|
2018 |
Cajigas-Du Ross CK, Martinez SR, Woods-Burnham L, Durán AM, Roy S, Basu A, Ramirez JA, Ortiz-Hernández GL, Ríos-Colón L, Chirshev E, Sanchez-Hernandez ES, Soto U, Greco C, Boucheix C, Chen X, et al. RNA sequencing reveals upregulation of a transcriptomic program associated with stemness in metastatic prostate cancer cells selected for taxane resistance. Oncotarget. 9: 30363-30384. PMID 30100995 DOI: 10.18632/Oncotarget.25744 |
0.634 |
|
2018 |
Woods-Burnham L, Stiel L, Wilson C, Montgomery S, Durán AM, Ruckle HR, Thompson RA, De León M, Casiano CA. Physician Consultations, Prostate Cancer Knowledge, and PSA Screening of African American Men in the Era of Shared Decision-Making. American Journal of Men's Health. 1557988318763673. PMID 29658371 DOI: 10.1177/1557988318763673 |
0.673 |
|
2018 |
Ross CKC, Woods-Burnham L, Ramirez J, Chen X, Wang C, Casiano CA. Abstract 5902: RNA sequencing analysis of taxane-resistant prostate cancer cells reveals potential candidate genes for therapeutic targeting Cancer Research. 78: 5902-5902. DOI: 10.1158/1538-7445.Am2018-5902 |
0.794 |
|
2018 |
Woods-Burnham L, Ross CKC, Basu A, Sanchez ES, Love A, Casiano CA. Abstract 5043: Glucocorticoids trigger GR-mediated expression of the chemoresistance-associated oncoproteins LEDGF/p75 and Clusterin: Implications for prostate cancer health disparities Cancer Research. 78: 5043-5043. DOI: 10.1158/1538-7445.Am2018-5043 |
0.843 |
|
2017 |
Woods-Burnham L, Basu A, Cajigas-Du Ross CK, Love A, Yates C, De Leon M, Roy S, Casiano CA. The 22Rv1 prostate cancer cell line carries mixed genetic ancestry: Implications for prostate cancer health disparities research using pre-clinical models. The Prostate. PMID 29030865 DOI: 10.1002/Pros.23437 |
0.805 |
|
2017 |
Woods-Burnham L, Love A, Ross CKC, Basu A, Stiel L, Montgomery S, Wilson C, Casiano CA. Abstract C43: Glucocorticoid-mediated upregulation of stress oncoproteins: Implications for prostate cancer health disparities Cancer Epidemiology, Biomarkers & Prevention. 26. DOI: 10.1158/1538-7755.Disp16-C43 |
0.828 |
|
2017 |
Woods-Burnham L, Stiel L, Wilson C, Montgomery S, Casiano CA. Abstract A56: Physician consultations, prostate cancer knowledge, and PSA screening in African American men: Are the conversations effective? Cancer Epidemiology, Biomarkers & Prevention. 26. DOI: 10.1158/1538-7755.Disp16-A56 |
0.685 |
|
2017 |
Woods-Burnham L, Love A, Ross CKC, Stiel L, Sanchez ES, Amponsah K, Montgomery S, Wilson C, Casiano CA. Abstract 5285: Glucocorticoid-mediated upregulation of stress oncoproteins: implications for prostate cancer health disparities Cancer Research. 77: 5285-5285. DOI: 10.1158/1538-7445.Am2017-5285 |
0.719 |
|
2017 |
Ross CKC, Rios-Colon L, Woods-Burnham L, Casiano CA. Abstract 4167: Co-targeting the stress survival proteins LEDGF/p75 and clusterin to resensitize chemoresistant prostate cancer cells to docetaxel Cancer Research. 77: 4167-4167. DOI: 10.1158/1538-7445.Am2017-4167 |
0.834 |
|
2015 |
Basu A, Woods-Burnham L, Ortiz G, Rios-Colon L, Figueroa J, Albesa R, Andrade LE, Mahler M, Casiano CA. Specificity of antinuclear autoantibodies recognizing the dense fine speckled nuclear pattern: Preferential targeting of DFS70/LEDGFp75 over its interacting partner MeCP2. Clinical Immunology (Orlando, Fla.). 161: 241-250. PMID 26235378 DOI: 10.1016/J.Clim.2015.07.014 |
0.736 |
|
Show low-probability matches. |